Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Cell Reports
|
May 6, 2014
A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
Luigi Mari, Francesca Milano, Kaushal Parikh, et al.
The Oncologist
|
December 25, 2019
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)
Kaushal Parikh, Sumithra J Mandrekar, Katie Allen-Ziegler, et al.
Resuscitation
|
January 7, 2018
Use of therapeutic hypothermia among patients with coagulation disorders - A Nationwide analysis
Mahek Shah, Kaushal Parikh, Brijesh Patel, et al.
Plos One
|
July 27, 2019
Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model
Danielle Straub, Ronald P J Oude Elferink, Peter L M Jansen, et al.
Plos One
|
August 4, 2009
Comparison of peptide array substrate phosphorylation of c-Raf and mitogen activated protein kinase kinase kinase 8
Kaushal Parikh, Sander H Diks, Jurriaan H B Tuynman, et al.
JAMIA Open
|
November 7, 2024
Targetable molecular algorithm and training platform development for the treatment of non-small cell lung cancer
Krithika Bhuvaneshwar, Chul Kim, Kaushal Parikh, et al.
Clinical Lung Cancer
|
May 16, 2026
Immune Checkpoint Inhibitors in Unresectable or Metastatic Thymic Epithelial Tumors--A Real-World Assessment of Efficacy and Toxicity
Guilherme Sacchi de Camargo Correia, Reema Tawfiq, Ruqin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2026
Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors
Hiba Mechahougui, Léna Royston, Catia Vieira Gomes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 17, 2024
Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM database
Kaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, et al.
CA: a Cancer Journal for Clinicians
|
July 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management
Maxime Borgeaud, Timothée Olivier, Jair Bar, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Cell Reports
|
May 6, 2014
A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
Luigi Mari, Francesca Milano, Kaushal Parikh, et al.
The Oncologist
|
December 25, 2019
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)
Kaushal Parikh, Sumithra J Mandrekar, Katie Allen-Ziegler, et al.
Resuscitation
|
January 7, 2018
Use of therapeutic hypothermia among patients with coagulation disorders - A Nationwide analysis
Mahek Shah, Kaushal Parikh, Brijesh Patel, et al.
Plos One
|
July 27, 2019
Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model
Danielle Straub, Ronald P J Oude Elferink, Peter L M Jansen, et al.
Plos One
|
August 4, 2009
Comparison of peptide array substrate phosphorylation of c-Raf and mitogen activated protein kinase kinase kinase 8
Kaushal Parikh, Sander H Diks, Jurriaan H B Tuynman, et al.
JAMIA Open
|
November 7, 2024
Targetable molecular algorithm and training platform development for the treatment of non-small cell lung cancer
Krithika Bhuvaneshwar, Chul Kim, Kaushal Parikh, et al.
Clinical Lung Cancer
|
May 16, 2026
Immune Checkpoint Inhibitors in Unresectable or Metastatic Thymic Epithelial Tumors--A Real-World Assessment of Efficacy and Toxicity
Guilherme Sacchi de Camargo Correia, Reema Tawfiq, Ruqin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2026
Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors
Hiba Mechahougui, Léna Royston, Catia Vieira Gomes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 17, 2024
Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM database
Kaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, et al.
CA: a Cancer Journal for Clinicians
|
July 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management
Maxime Borgeaud, Timothée Olivier, Jair Bar, et al.
Page
of 9